Training Effects on Fuel Metabolism

Healthy Subjects Clinical Trial

— TrainMeUpMN  

Official title:

Training Effects on Fuel Metabolism

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02150889
• Other study ID #: 1209M20741
• Secondary ID: 5R01DK098203-02
• Status: Active, not recruiting
• Phase: N/A
• Start date: July 1, 2014
• Est. completion date: December 30, 2025

Study information

• Verified date: November 2023
• Source: University of Minnesota
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators are interested in how skeletal muscle processes fat and how this may affect insulin resistance. This is an important question since insulin resistance predates and predicts type 2 diabetes. The investigators are especially interested in learning about the effects of weight and training on insulin resistance. The investigators will study people before and after supervised aerobic or yoga training to identify differences in resting fat and sugar metabolism which may lead to differences in insulin resistance. The investigators will test these differences using stable isotopes, and the use of these stable isotopes is experimental.

Overweight/Obese Group: Eight visits will be required at the University of Minnesota Clinical Research Unit. Four visits will be done before training (screen and 3 pre-training visits), 1 visit during the training, and 3 post-training visits will be done. In between, the training will take about 16 weeks and will be a supervised treadmill program.

Lean/Trained Group: Four visits will be required at the University of Minnesota Clinical Research Unit (screen and 3 study visits).

Description:

Insulin resistance plays a critical role in the development of type 2 diabetes (T2DM), with skeletal muscle the largest site of insulin resistance in the human body. In sedentary humans, insulin resistance correlates with levels of intramyocellular lipid (IMCL) and lipid metabolites that adversely affect skeletal muscle glucose metabolism. However, even modest endurance training has been shown to reduce insulin resistance while increasing skeletal muscle IMCL. Moreover, lean endurance trained participants have IMCL levels comparable to those of patients with T2DM, yet have significantly lower insulin resistance. These findings suggest that the physiological changes caused by training protect against lipid induced insulin resistance and that this protection is present even at rest, however our preliminary data suggest that training facilitates utilization of readily available fuel, with lipid preferentially used over glucose when available. We will test the overarching hypothesis that training increases resting skeletal muscle lipid metabolism, as measured by markers of IMCL lipolysis, accumulation of fatty acid metabolites and mitochondrial utilization of fatty acids.

Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1-TR002494. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 64
• Est. completion date: December 30, 2025
• Est. primary completion date: December 30, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

All subjects

1. Subjects 18 to 40 years of age.

2. Subjects are capable of giving informed consent

Overweight or obese

1. Insulin resistant based on screening oral glucose tolerance testing.

2. BMI 25 to 40 kg/m2 inclusive

3. Stable weight for at least 3 months (± 5 lbs.)

4. Sedentary status (self-report < 30 minutes/week regular exercise).

Lean, physically active

1. physically active subjects defined as 3-5 aerobic exercise sessions/week

2. matched to age and gender

3. generally healthy with normal fasting glucose levels (glucose =100 mg/dL).

Exclusion Criteria:

All subjects

1. Subjects 18 to 40 years of age.

2. Subjects are capable of giving informed consent

Overweight or obese

1. Insulin resistant based on screening oral glucose tolerance testing.

2. BMI 25 to 40 kg/m2 inclusive

3. Stable weight for at least 3 months (± 5 lbs.)

4. Sedentary status (self-report < 30 minutes/week regular exercise).

Lean, physically active

1. physically active subjects defined as 3-5 aerobic exercise sessions/week

2. matched to age and gender

3. generally healthy with normal fasting glucose levels (glucose =100 mg/dL).

Related Conditions & MeSH terms

• Healthy Subjects
• Lean Trained Subjects
• Overweight
• Overweight and Obesity

Intervention

Behavioral:
• Running Program
16 week supervised running program
• Yoga Program
once weekly supervised yoga

Locations

Country	Name	City	State
United States	University of Minnesota	Minneapolis	Minnesota

Sponsors (3)

Lead Sponsor	Collaborator
University of Minnesota	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Differences in body composition between groups	we will measure body composition by iDEXA to look at changes and total fat, visceral fat, and subcutaneously pre-and post exercise. This will be a noninvasive x-ray based measurement (x-ray exposure is extremely low and is equivalent to 1 day of natural radiation in Minnesota)	before and after exercise program ((exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
Primary	Differences in insulin sensitivity between groups	Will use HOMA-IR and hyperinsulinemia-euglycemic clamp	Before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
Secondary	Differences in fitness level between groups	we will measure fitness level by treadmill based VO2 max testing.	before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)